News

Earlier this year, we officially opened our first funding call, an important milestone for the ImmuneHealth-4-All programme. This call is specifically designed to take promising results from previous ImmuneHealthXL projects and translate them further towards real patient impact.

The ImmuneHealth-4-All programme has been awarded €6.6 million in funding through the Health~Holland PPS programme to stimulate public-private partnerships. The programme stems from ImmuneHealthXL (IHXL), a national initiative promoting disease-overarching immunological research in immune-mediated inflammatory diseases (IMIDs).

IHXL researcher and Radboudumc rheumatologist Rogier Thurlings found a powerful answer: by co-creating a cartoon book with his 10-year-old son Valentijn in close collaboration with patients and patient organizations.

At the heart of ImmuneHealthXL's strategy are four ambitious moonshots. In the ImmuneHealthXL Moonshot webinar, the moonshots are introduces and explained by experts in the field.

ImmuneHealth XL is organising a Stakeholder Meeting on December 9 in the afternoon. Please mark your calendar for this event and register below. 

ImmunHealthXl will host a webinar series highlighting the four ambitious moonshots that are at the heart of IHXL's strategy. The goal of the moonshots is to build communities, guide collaboration, spark initiatives, unlock funding opportunities, and translate discoveries into real impact for patients.

The National Science Agenda (NWA) granted 14 consortia with funding, including the META-IMMUNOTYPES consortium. The consortium will focus on smart technology and blood tests to make the early detection of chronic diseases possible and ImmuneHealthXL will be part of the consortium.